GLP1R and cardiovascular disorder: The GLP‐1 RA treatment arm patients were younger, more likely to be of white ethnicity, female and with a higher BMI, HbA1c, and eGFR, as well as less cardiovascular disease, compared with the DPP4i arm (Table 1).